Cargando…
Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives
Recent advances in the treatment of spinal muscular atrophy (SMA) have dramatically altered prognosis. Rather than a rapidly lethal disease, SMA type 1, the most severe form with the earliest onset of SMA, has become a disease in which long-term event-free survival with the acquisition of important...
Autores principales: | Dangouloff, Tamara, Servais, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778729/ https://www.ncbi.nlm.nih.gov/pubmed/31632042 http://dx.doi.org/10.2147/TCRM.S172291 |
Ejemplares similares
-
Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review
por: Aragon-Gawinska, Karolina, et al.
Publicado: (2023) -
Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments
por: Dangouloff, Tamara, et al.
Publicado: (2021) -
Proximal spinal muscular atrophy: current orthopedic perspective
por: Haaker, Gerrit, et al.
Publicado: (2013) -
Prognostic Factors and Treatment‐Effect Modifiers in Spinal Muscular Atrophy
por: Baranello, Giovanni, et al.
Publicado: (2021) -
Current and emerging treatment options for spinal muscular atrophy
por: Farooq, Faraz, et al.
Publicado: (2015)